Analysis and Evolution of Profit and Net Profit Margin in the Pharmaceutical Industry in Romania
Profit is considered to be an important source of financing the financial activity of any economic entity. The main purpose of any activity is to make a profit. As a significant part of equity, employees can be remunerated from profit (as part of their profit share) and also shareholders/associations can be also remunerated in the form of distributed dividends. The appreciation of financial performance is closely linked to the ability to make a profit. In this sense, the main purpose of this article is to analyze and describe the evolution of profit and net profit margin, as an indicator of performance appreciation, for economic entities in the field of manufacture of basic pharmaceutical products in Romania. The basis of the analysis is the annual financial statements for a number of 46 entities for the period 1999-2018 (20 years). The results of the research show that, from the point of view of the evolution of the number of entities that register profit, we are witnessing an increase from 12 entities in 1999 to 23 entities in 2018. However, referring to the increase in the number of entities from a total of 17 in 1999 to 46 entities in 2018, we notice that in 2018 only half of them register a profit. The other half falls into the category of less performing entities due to losses. However, after a period of financial decline (2008-2009) we see a gradual increase in profits recorded by economic entities in the pharmaceutical industry in Romania.
Barbuta MN. The Effect of Leverage on Profitability of Pharmaceutical Companies. Economics and Applied Informatics, "Dunarea de Jos" University of Galati, Faculty of Economics and Business Administration. 2013;1:45-52.
Burja C. Economic-financial analysis: methodological aspects and practical applications. Cluj-Napoca: Casa Cărţii de Ştiinţă Publishing House; 2009.
Carp A, Mirea M. Profitability as a form of communication of the value of an entity that operates for profit. Romanian Statistical Review. 2017;Sup6: 184-191.
Deng Y, Zou S, You D. Financial performance evaluation of nuclear power-related enterprises from the perspective of sustainability, Environmental Science and Pollution Research. 2020;27:1-15. 10.1007/s11356-019-07545-1.
DeNisi AS, Pritchard R. Performance Appraisal, performance management and improving individual performance: a motivational framework. Management and Organization Review. 2006;2(2):253-277.
Dita AH, Murtaqi I. The effect of net profit margin, price to book value and debt to equity ratio to stock return in the Indonesian consumer goods industry. Journal of Business and Management. 2014;3(3):305-315.
Ejike SI, Agha NC. Impact of Operating Liquidity on Profitability of Pharmaceutical Firms in Nigeria. International Journal of Academic Research in Accounting, Finance and Management Sciences, Human Resource Management Academic Research Society, International Journal of Academic Research in Accounting, Finance and Management Sciences. 2018;8(3):73-82.
Fenyves V, Nyul B, Dajnoki K, Bacs Z, Tomori G. Profitability of Pharmaceutical Companies in the VisegrÃ¡d Countries. Montenegrin Journal of Economics, Economic Laboratory for Transition Research (ELIT). 2019;15(4):99-111.
Khajar I, Hersugondo H, Udin U. Privatization and financial performance: evidence from Indonesia.Quality. 2019;20(173):107-110.
Kolodziejka K. Pharmaceutical sector in the new reimbursement era. Management. 2012;16(1):203-215.
Nishanthini A, Nimalathasan B. Determinants of Profitability: A Case Study of Listed Manufacturing Companies in Sri Lanka. Journal of Management. 2013;VIII(1):42-50.
Pintea MO. Performance evaluation: literature review and time evolution. Annals of Faculty of Economics, University of Oradea, Faculty of Economics. 2012;1(1):753-758.
Srivastava A. Diagnosing inter firm profitability of pharmaceutical industry: an empirical analysis for India. Technology Science Journal. 2017;9(9):32-36.
Stănică FA, Străchinaru AI, Ilie V. Influences on the profitability of the pharmaceutical industry in Romania. Theoretical and Applied Economics, Asociatia Generala a Economistilor din Romania – AGER. 2015;0(Special I):97-105.
Stog I., The Romanian pharmaceutical market increased by 13.4% in 2018, to 3.4 billion euros, [Internet], 2019, Available from: https://www.wall-street.ro/articol/Companii/240670/piata-farmaceutica-din-romania-a-crescut-cu-13-4-in-2018-la-3-4-miliarde-euro.html
Institutul de Prognoză Economică. The pharmaceutical industry in Romania: the main trends and the impact on society and the economy [Internet]. [Updated February 2012]. Available from: http://www.lawg.ro/files/assets/userfiles/files/Industria%20Farmaceutica%20din%20Romania.pdf
Top Firme [Internet]. Available from: www.topfirme.com
Ministerul Finanţelor Publice [Internet]. Available from: www.mfinante.ro
Copyright (c) 2020 LUMEN Proceedings
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Selection and peer-review under responsibility of the Organizing Committee of the conference.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited